{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:11:26Z","timestamp":1790518286212,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["PICT 2014-0476"],"award-info":[{"award-number":["PICT 2014-0476"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["2014-1121"],"award-info":[{"award-number":["2014-1121"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"crossref","award":["PIP 0240"],"award-info":[{"award-number":["PIP 0240"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"crossref","award":["PIP 0202"],"award-info":[{"award-number":["PIP 0202"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tox.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T04:17:48Z","timestamp":1503461868000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats"],"prefix":"10.1016","volume":"390","author":[{"given":"Maite Roc\u00edo","family":"Arana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Nicol\u00e1s","family":"Tocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Zecchinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sof\u00eda","family":"Londero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Rigalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina Stella Maris","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Domingo","family":"Mottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2017.08.007_bib0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2015.06.003","article-title":"Coordinated induction of GST and MRP2 by cAMP in Caco-2 cells: role of protein kinase A signaling pathway and toxicological relevance","volume":"287","author":"Arana","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2017.08.007_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2016.04.014","article-title":"Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier","volume":"109","author":"Arana","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2017.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.108.025643","article-title":"Regulation of expression and activity of rat intestinal multidrug resistance-associated protein 2 by cholestatic estrogens","volume":"37","author":"Arias","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2017.08.007_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/0929867043456098","article-title":"Mode of action of endotoxin: role of free radicals and antioxidants","volume":"11","author":"Bhattacharyya","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2017.08.007_bib0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ibd.20088","article-title":"Decreased P-glycoprotein (P-gp\/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels","volume":"13","author":"Blokzijl","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tox.2017.08.007_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/jpet.105.085373","article-title":"Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2","volume":"314","author":"Cameron","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2017.08.007_bib0035","doi-asserted-by":"crossref","first-page":"G905","DOI":"10.1152\/ajpgi.00231.2002","article-title":"Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy","volume":"284","author":"Cameron","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-Week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tox.2017.08.007_bib0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1590\/0102-6720201600040014","article-title":"Glp-2: a poorly understood mediator enrolled in various bariatric\/metabolic surgery-related pathophysiologic mechanisms","volume":"29","author":"Cazzo","year":"2016","journal-title":"Arq. Bras. Cir. Dig. (S\u00e3o Paulo)"},{"key":"10.1016\/j.tox.2017.08.007_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ibd.20375","article-title":"Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(\u2212\/\u2212) mice","volume":"14","author":"Collett","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tox.2017.08.007_bib0055","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.domaniend.2015.11.008","article-title":"Glucagon-like peptide 2 and its beneficial effects on gut function and health in production animals","volume":"56","author":"Connor","year":"2016","journal-title":"Domest. Anim. Endocrinol."},{"key":"10.1016\/j.tox.2017.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/gut.52.12.1788","article-title":"ABC of oral bioavailability: transporters as gatekeepers in the gut","volume":"52","author":"Dietrich","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.tox.2017.08.007_bib0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/en.2013-1871","article-title":"The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function","volume":"155","author":"Dong","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tox.2017.08.007_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1146\/annurev-physiol-021113-170317","article-title":"Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2","volume":"76","author":"Drucker","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0003-2697(80)90139-6","article-title":"Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine","volume":"106","author":"Griffith","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tox.2017.08.007_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13318-014-0174-0","article-title":"Changes of absorptive and secretory transporting system of (1\u20133) beta-D-glucan based on efflux transporter in indomethacin-induced rat","volume":"40","author":"Iida","year":"2015","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tox.2017.08.007_bib0085","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1517\/17425250903008525","article-title":"Altered functions and expressions of drug transporters in liver, kidney and intestine in disorders of local and remote organs: possible role of oxidative stress in the pathogenesis","volume":"5","author":"Ikemura","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2017.08.007_bib0090","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/0024-3205(81)90610-X","article-title":"Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia","volume":"29","author":"Jacobs","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2017.08.007_bib0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","article-title":"Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide \u2013 analyses from a randomised, placebo-controlled study","volume":"32","author":"Jeppesen","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.tox.2017.08.007_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/dmd.32.1.20","article-title":"Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats","volume":"32","author":"Kalitsky-Szirtes","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2017.08.007_bib0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/SPC.0000000000000132","article-title":"Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis","volume":"9","author":"Kissow","year":"2015","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.tox.2017.08.007_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1081\/DMR-120026398","article-title":"Regulation of drug and bile salt transporters in liver and intestine","volume":"35","author":"Kullak-Ublick","year":"2003","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2017.08.007_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.11.015","article-title":"Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis","volume":"315","author":"Lambertucci","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2017.08.007_bib0120","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/TA.0000000000001008","article-title":"Exogenous S-nitrosoglutathione attenuates inflammatory response and intestinal epithelial barrier injury in endotoxemic rats","volume":"80","author":"Li","year":"2016","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.tox.2017.08.007_bib0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jnutbio.2016.11.002","article-title":"Intestinal multidrug resistance-associated protein 2 is down-regulated in fructose-fed rats","volume":"40","author":"Londero","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tox.2017.08.007_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2017.08.007_bib0135","first-page":"713","article-title":"Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide \u2013 analyses from a randomised, placebo-controlled study","volume":"32","author":"Madsen","year":"2013","journal-title":"Regul. Pept."},{"key":"10.1016\/j.tox.2017.08.007_bib0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00280-016-3165-9","article-title":"Irinotecan \u2013 induced mucositis: the interactions and potential role of GLP \u2013 2 analogues","volume":"79","author":"Mayo","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2017.08.007_bib0145","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0002-9440(10)61196-0","article-title":"Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats","volume":"167","author":"Moriez","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2017.08.007_bib0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2007.02.058","article-title":"Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity","volume":"565","author":"Moriguchi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2017.08.007_bib0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-3565(24)39291-2","article-title":"Expression and localization of multidrug resistant protein mrp2 in rat small intestine","volume":"293","author":"Mottino","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2017.08.007_bib0160","doi-asserted-by":"crossref","first-page":"G1261","DOI":"10.1152\/ajpgi.2001.280.6.G1261","article-title":"Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats","volume":"280","author":"Mottino","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0165","doi-asserted-by":"crossref","first-page":"G391","DOI":"10.1152\/ajpgi.00496.2006","article-title":"Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17beta-D-glucuronide-induced cholestasis","volume":"293","author":"Mottino","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0170","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.106.112631","article-title":"Down-regulation of intestinal drug transporters in chronic renal failure in rats","volume":"320","author":"Naud","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2017.08.007_bib0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tox.2017.08.007_bib0180","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","article-title":"A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis","volume":"161","author":"Panwala","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2017.08.007_bib0185","first-page":"99","article-title":"Vanja Petrovic, Shirley Teng, and Micheline Piquette-Miller","volume":"7","author":"Petrovic","year":"2007","journal-title":"Rev. Lit. Arts Am."},{"key":"10.1016\/j.tox.2017.08.007_bib0190","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.3748\/wjg.14.6786","article-title":"Dynamic localization of hepatocellular transporters in health and disease","volume":"14","author":"Roma","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2017.08.007_bib0195","first-page":"G1035","article-title":"Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status","volume":"295","author":"Sekine","year":"2008","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0200","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00530.2006","article-title":"Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2","volume":"293","author":"Sigalet","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2017.08.007_bib0205","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/0148607113520005","article-title":"Pathophysiology of short bowel syndrome","volume":"38","author":"Tappenden","year":"2014","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.tox.2017.08.007_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2016.05.002","article-title":"Modulation of expression and activity of intestinal multidrug resistance-associated protein 2 by xenobiotics","volume":"303","author":"Tocchetti","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2017.08.007_bib0215","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tox.2017.08.007_bib0220","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.110.171041","article-title":"Induction of intestinal multidrug resistance-associated protein 2 by glucagon-like Peptide 2 in the rat","volume":"335","author":"Villanueva","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2017.08.007_bib0225","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2016.11.112","article-title":"Sodium butyrate attenuates soybean oil-based lipid emulsion-induced increase in intestinal permeability of lipopolysaccharide by modulation of P-glycoprotein in Caco-2 cells","volume":"482","author":"Yan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tox.2017.08.007_bib0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/micr.20491","article-title":"Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats","volume":"28","author":"Zhang","year":"2008","journal-title":"Microsurgery"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X17302330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X17302330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:35:38Z","timestamp":1759534538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X17302330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":46,"alternative-id":["S0300483X17302330"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2017.08.007","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}